Innate immunity limits protective adaptive immune responses against pre-erythrocytic malaria parasites.
Adaptive Immunity
/ immunology
Animals
CD8-Positive T-Lymphocytes
/ immunology
Erythrocytes
/ immunology
Female
Immunity, Innate
/ immunology
Immunization
Interferon Type I
/ immunology
Liver
/ immunology
Malaria
/ immunology
Malaria Vaccines
/ administration & dosage
Mice, Inbred C57BL
Mice, Knockout
Plasmodium yoelii
/ immunology
Sporozoites
/ immunology
Vaccines, Attenuated
/ administration & dosage
Journal
Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555
Informations de publication
Date de publication:
02 09 2019
02 09 2019
Historique:
received:
28
06
2018
accepted:
06
08
2019
entrez:
4
9
2019
pubmed:
4
9
2019
medline:
31
12
2019
Statut:
epublish
Résumé
Immunization with attenuated whole Plasmodium sporozoites constitutes a promising vaccination strategy. Compared to replication-deficient parasites, immunization with replication-competent parasites confers better protection and also induces a type I IFN (IFN-1) response, but whether this IFN-1 response has beneficial or adverse effects on vaccine-induced adaptive immunity is not known. Here, we show that IFN-1 signaling-deficient mice immunized with replication-competent sporozoites exhibit superior protection against infection. This correlates with superior CD8 T cell memory including reduced expression of the exhaustion markers PD-1 and LAG-3 on these cells and increased numbers of memory CD8 T cells in the liver. Moreover, the adoptive transfer of memory CD8 T cells from the livers of previously immunized IFN-1 signaling-deficient mice confers greater protection against liver stage parasites. However, the detrimental role of IFN-1 signaling is not CD8 T cell intrinsic. Together, our data demonstrate that liver stage-engendered IFN-1 signaling impairs hepatic CD8 T cell memory via a CD8 T cell-extrinsic mechanism.
Identifiants
pubmed: 31477704
doi: 10.1038/s41467-019-11819-0
pii: 10.1038/s41467-019-11819-0
pmc: PMC6718385
doi:
Substances chimiques
Interferon Type I
0
Malaria Vaccines
0
Vaccines, Attenuated
0
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
3950Subventions
Organisme : NIAID NIH HHS
ID : R01 AI114699
Pays : United States
Références
Cell. 2012 Mar 16;148(6):1284-92
pubmed: 22424235
Semin Immunopathol. 2012 Nov;34(6):787-92
pubmed: 23053392
Sci Transl Med. 2017 Jan 4;9(371):
pubmed: 28053159
J Immunol. 2002 Jul 1;169(1):375-83
pubmed: 12077267
J Exp Med. 1980 Jun 1;151(6):1504-13
pubmed: 6991628
PLoS Pathog. 2009 Apr;5(4):e1000399
pubmed: 19390607
Immunity. 2014 Dec 18;41(6):886-97
pubmed: 25526304
Int J Parasitol. 2004 Aug;34(9):991-6
pubmed: 15313126
J Clin Invest. 2014 Jun;124(6):2483-96
pubmed: 24789914
Nat Med. 2014 Jan;20(1):47-53
pubmed: 24362933
Infect Immun. 2015 Mar;83(3):1172-80
pubmed: 25583524
J Infect Dis. 2014 Nov 1;210(9):1508-16
pubmed: 24823625
J Immunol. 2013 May 15;190(10):5118-27
pubmed: 23585679
Science. 2013 Apr 12;340(6129):207-11
pubmed: 23580529
Cell Rep. 2014 Apr 24;7(2):436-447
pubmed: 24703850
J Immunol. 2015 Mar 1;194(5):2268-79
pubmed: 25646303
Nature. 2017 Feb 23;542(7642):445-449
pubmed: 28199305
Methods Mol Biol. 2013;923:549-66
pubmed: 22990804
Science. 2013 Apr 12;340(6129):202-7
pubmed: 23580528
J Immunol. 2018 Feb 15;200(4):1443-1456
pubmed: 29321276
Proc Natl Acad Sci U S A. 2008 Sep 16;105(37):14017-22
pubmed: 18780790
Cell Rep. 2016 Oct 4;17(2):399-412
pubmed: 27705789
Infect Immun. 2018 Apr 23;86(5):
pubmed: 29440367
Nat Rev Immunol. 2012 Nov;12(11):749-61
pubmed: 23080391
J Immunol. 2015 Mar 15;194(6):2455-65
pubmed: 25747907
Infect Immun. 2014 Apr;82(4):1460-4
pubmed: 24421043
Clin Transl Immunology. 2016 Oct 21;5(10):e105
pubmed: 27867517
J Immunotoxicol. 2010 Mar;7(1):1-7
pubmed: 20017587
Sci Immunol. 2017 Mar;2(9):
pubmed: 28707003
J Immunol. 2010 Mar 1;184(5):2528-38
pubmed: 20097864
Genes Immun. 2013 Jul-Aug;14(5):302-9
pubmed: 23594961
Cell Microbiol. 2009 Mar;11(3):506-20
pubmed: 19068099
Annu Rev Immunol. 2014;32:157-87
pubmed: 24655294
Nat Rev Immunol. 2015 Aug;15(8):486-99
pubmed: 26205583
FEBS J. 2017 Aug;284(16):2560-2568
pubmed: 28500775
Nat Rev Immunol. 2015 Feb;15(2):87-103
pubmed: 25614319
Nat Rev Immunol. 2010 Feb;10(2):80-1
pubmed: 20183893
Front Microbiol. 2014 Jun 06;5:272
pubmed: 24936199
Hum Vaccin. 2010 Jan;6(1):107-13
pubmed: 19838068
Front Immunol. 2018 Nov 09;9:2569
pubmed: 30473697
Expert Rev Vaccines. 2017 Jan;16(1):45-54
pubmed: 27327875
Immunity. 2016 Oct 18;45(4):889-902
pubmed: 27692609
Nat Rev Immunol. 2003 Apr;3(4):269-79
pubmed: 12669018
J Immunol. 1991 Feb 1;146(3):1020-5
pubmed: 1988490
Cell Host Microbe. 2011 Jun 16;9(6):451-62
pubmed: 21669394
Semin Immunol. 2012 Jun;24(3):209-17
pubmed: 22551764
Cell Host Microbe. 2019 Apr 10;25(4):565-577.e6
pubmed: 30905437
PLoS One. 2013 Apr 11;8(4):e60820
pubmed: 23593316
Infect Immun. 2014 Dec;82(12):5143-53
pubmed: 25267837